158 related articles for article (PubMed ID: 10352273)
1. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence.
Vallejo AN; Brandes JC; Weyand CM; Goronzy JJ
J Immunol; 1999 Jun; 162(11):6572-9. PubMed ID: 10352273
[TBL] [Abstract][Full Text] [Related]
2. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
Sepulveda H; Cerwenka A; Morgan T; Dutton RW
J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
[TBL] [Abstract][Full Text] [Related]
3. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
4. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
6. Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.
Salazar-Fontana LI; Sanz E; Mérida I; Zea A; Sanchez-Atrio A; Villa L; Martínez-A C; de la Hera A; Alvarez-Mon M
Clin Immunol; 2001 May; 99(2):253-65. PubMed ID: 11318597
[TBL] [Abstract][Full Text] [Related]
7. Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging.
Fann M; Chiu WK; Wood WH; Levine BL; Becker KG; Weng NP
Immunol Rev; 2005 Jun; 205():190-206. PubMed ID: 15882354
[TBL] [Abstract][Full Text] [Related]
8. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts.
Monteiro J; Batliwalla F; Ostrer H; Gregersen PK
J Immunol; 1996 May; 156(10):3587-90. PubMed ID: 8621891
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 7A1 is expressed in human CD4+ naïve T cells at higher levels than in CD4+ memory cells and is not required during their CD3/CD28-dependent activation.
Nueda A; García-Roger N; Domenech T; Godessart N; Cárdenas A; Santamaría-Babi LF; Beleta J
Cell Immunol; 2006 Jul; 242(1):31-8. PubMed ID: 17034773
[TBL] [Abstract][Full Text] [Related]
10. Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28.
Molinero LL; Fuertes MB; Rabinovich GA; Fainboim L; Zwirner NW
J Leukoc Biol; 2002 May; 71(5):791-7. PubMed ID: 11994503
[TBL] [Abstract][Full Text] [Related]
11. Premature senescence of T lymphocytes from patients with beta-thalassemia major.
Gharagozloo M; Bagherpour B; Tahanian M; Oreizy F; Amirghofran Z; Sadeghi HM; Hourfar H; Moayedi B
Immunol Lett; 2009 Jan; 122(1):84-8. PubMed ID: 19118576
[TBL] [Abstract][Full Text] [Related]
12. T cell replicative senescence: pleiotropic effects on human aging.
Effros RB
Ann N Y Acad Sci; 2004 Jun; 1019():123-6. PubMed ID: 15247004
[TBL] [Abstract][Full Text] [Related]
13. Proliferation and apoptosis of human CD8(+)CD28(+) and CD8(+)CD28(-) lymphocytes during aging.
Brzezińska A; Magalska A; Szybińska A; Sikora E
Exp Gerontol; 2004 Apr; 39(4):539-44. PubMed ID: 15050288
[TBL] [Abstract][Full Text] [Related]
14. The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age.
Simone R; Zicca A; Saverino D
J Leukoc Biol; 2008 Dec; 84(6):1454-61. PubMed ID: 18780874
[TBL] [Abstract][Full Text] [Related]
15. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
Koehler H; Kofler D; Hombach A; Abken H
Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
[TBL] [Abstract][Full Text] [Related]
16. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
[TBL] [Abstract][Full Text] [Related]
17. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
Watson CL; Furlong SJ; Hoskin DW
Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
[TBL] [Abstract][Full Text] [Related]
18. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
19. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
[TBL] [Abstract][Full Text] [Related]
20. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
